Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica ›› 2011, Vol. 33 ›› Issue (3): 272-276.doi: 10.3881/j.issn.1000-503X.2011.03.013

Previous Articles     Next Articles

Effectiveness and Safety of Laparoscopic Roux-en-Y Gastric Bypass in Treating Type 2 Diabetes Mellitus in Non-morbidly Obese Patients

HUANG Chih-kun   

  1. Bariatric & Metabolic International Surgery Center, International Minimally Invasive Surgery Training Center, E Da Hospital, Taiwan Obesity Support Association, Kaohsiung County, Taiwan 824, China
  • Received:2011-04-19 Revised:2011-07-01 Online:2011-07-01 Published:2011-07-01

Abstract: ObjectiveTo evaluate the effectiveness of laparoscopic Roux-en-Y gastric bypass (LRYGB) for achieving type 2 diabetes mellitus (T2DM) remission in patients with body mass index (BMI) in the range of 25-35 kg/m2. MethodsTwenty-two non-morbidly obese (BMI: 25-35 kg/m2) patients with T2DM underwent LRYGB. The changes of BMI, fasting plasma glucose (FPG), and glycosylated hemoglobin (HbA1c) levels were recorded, and the prognostic factors were analyzed. ResultsAll these 22 patients successfully underwent LRYGB and were followed up for twelve months. Two patients (9.1%) developed complications: one patient had an early hemorrhage at the gastrojejunostomy site, and the other had frequent loose stools that required revision surgery. At 12 months, 14 patients (63.6%) showed T2DM remission, 6 (27.3%) showed glycemic control, and 2(9.1%) showed improvement. Compared with the latter two groups, patients in the T2DM remission group had significantly higher BMI (P=0.001), younger age (P=0.002), and shorter duration of diabetes (P=0.001) before operation. ConclusionsLYRGB can efficiently and safely treat T2DM in non-morbidly obese patients. Early intervention in these patients may yield better outcomes.

Key words: laparoscopic Roux-en-Y gastric bypass, type 2 diabetes mellitus, non-morbid obesity

CLC Number: